Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy

Circulation

Volumn 103, Issue 2, 2001, Pages 253-257

  Glatter, Kathy ^a   Yang, Yanfei ^a   Chatterjee, Kanu ^a   Modin, Gunnard ^a   Cheng, Jie ^b   Kayser, Steve ^a   Scheinman, Melvin M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Amiodarone; Arrhythmia; Atrial flutter; Cardioversion; Fibrillation; Ibutilide; Torsade de pointes

Indexed keywords

AMIODARONE; IBUTILIDE;

AGED; ARTICLE; CARDIOVERSION; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; TORSADE DES POINTES;

EID: 0035895318     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.2.253     Document Type: Article

References (28)

1. Kr) in AT-cells
2. Kr and effects on myocardial refractoriness for class III antiarrhythmic agents
3. Ibutilide: Enhanced defibrillation via plateau sodium current activation
4. Ibutilide: Review
5. Ibutilide and the treatment of atrial arrhythmias
6. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation
7. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation
8. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study
9. Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter
10. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation
11. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery
12. Amiodarone: An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias
13. Electropharmacology of amiodarone therapy initiation
14. Effects of amiodarone, sematilide, and sotalol on QT dispersion
15. Amiodarone-associated proarrhythmic effects
16. Amiodarone in patients with previous drug-mediated torsade de pointes
17. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment
18. Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide
19. Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion
20. Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values
21. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations
22. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome
23. Characteristics and distribution of M cells in arterially perfused canine left ventricular wedge preparations
24. Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart
25. Barium-induced nondriven action potentials as a model of triggered potentials from early afterdepolarizations